Latest approaches for the treatment of obesity
2015 · Expert Opinion on Drug Discovery · 126 citations
https://doi.org/10.1517/17460441.2015.1044966
P
Philip A. Carpino
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
2.0K
Citations
26
h-index
41
i10-index
Philip A. Carpino is an academic researcher from Xenon Pharmaceuticals (Canada). The author has contributed to research in topics: Regulation of Appetite and Obesity & Chemical Synthesis and Analysis & Cannabis and Cannabinoid Research. The author has an h-index of 26, co-authored 60 publications.
ORCID: 0000-0002-7399-0717Papers by this author
worksInvestigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies
2014 · Expert Opinion on Investigational Drugs · 23 citations
https://doi.org/10.1517/13543784.2014.918952
Quantitative in vitro and in vivo pharmacological profile of CE-178253, a potent and selective cannabinoid type 1 (CB1) Receptor Antagonist
2010 · BMC Pharmacology · 14 citations
https://doi.org/10.1186/1471-2210-10-9
Rational Design of Macrocyclic Noncovalent Inhibitors of SARS-CoV-2 M<sup>pro</sup> from a DNA-Encoded Chemical Library Screening Hit That Demonstrate Potent Inhibition against Pan-Coronavirus Homologues and Nirmatrelvir-Resistant Variants
2024 · Journal of Medicinal Chemistry · 4 citations
https://doi.org/10.1021/acs.jmedchem.4c02009
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat